C07K 14/595
Gastrins
Official title: Gastrins; Cholecystokinins [CCK]
C07K14/595 (Gastrins) appears on 80 US grants and 58 published applications in this corpus.
Search patents in C07K- Granted patents
- 80
- Published applications
- 58
- Assignees
- 67
- Inventors
- 259
- Latest grant
- 11 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 2 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 2 | 0 |
| 1984 | 2 | 0 |
| 1985 | 4 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 5 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 6 | 0 |
| 1998 | 7 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 2 |
| 2002 | 2 | 3 |
| 2003 | 1 | 1 |
| 2004 | 1 | 7 |
| 2005 | 2 | 6 |
| 2006 | 1 | 4 |
| 2007 | 1 | 4 |
| 2008 | 3 | 1 |
| 2009 | 0 | 5 |
| 2010 | 1 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 3 |
| 2014 | 1 | 1 |
| 2015 | 2 | 1 |
| 2016 | 0 | 2 |
| 2017 | 2 | 3 |
| 2018 | 1 | 1 |
| 2019 | 2 | 1 |
| 2020 | 0 | 2 |
| 2021 | 2 | 3 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 1 | 1 |
| 2025 | 1 | 2 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (GRPR) and treatment of GRPR-related disorders11 Mar 2025US 12,246,076 B2Provincial Health Services Authority
- Pharmacokinetics and cholecystokinin-2 receptor (CCK2R) targeting for diagnosis and therapy30 Jul 2024US 12,049,518 B2Medizinische Universität Innsbruck
- Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment11 Apr 2023US 11,623,014 B2Paul Scherrer Institut
- Coiled-coil connector17 Aug 2021US 11,090,381 B2Oncoqr Ml GmbH
- Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment23 Mar 2021US 10,953,114 B2Paul Scherrer Institut
- Dual receptor targeting radioligands and uses thereof related applications27 Aug 2026US 2026/0248972 A1Full-Life Technologies HK Limited
- Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders27 Aug 2026US 2026/0248973 A1Provincial Health Services Authority
- Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders19 Jun 2025US 2025/0195702 A1Provincial Health Services Authority
- Pharmacokinetics and cholecystokinin-2 receptor (cck2r) targeting for diagnosis and therapy16 Jan 2025US 2025/0019402 A1Medizinische Universität Innsbruck
- Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders18 Apr 2024US 2024/0123099 A1The University of British Columbia
Most cited
By later US patents
- Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines76US 5,759,551 AUnited Biomedical, Inc. · 1998
- Method for preparing peptides and intermediate products60US 4,507,235 AMax-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V. · 1985
- Bispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicity54US 5,833,985 AMedarex, Inc. · 1998
- Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease41US 5,023,077 AAphton Corporation · 1991
- Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines36US 5,843,446 AUnited Biomedical, Inc. · 1998